publication . Article . 2008

DETERMINATION OF DOSIMETRIC PARAMETERS OF THE SECOND MODEL OF PD-103 SEED MANUFACTURED AT AGRICULTURAL, MEDICAL AND INDUSTRIAL RESEARCH SCHOOL

Mahdi Sadeghi;
  • Published: 01 Jun 2008
Abstract
Introduction: The use of low energy isotopes such as  103 Pd in brachytherapy for the treatment of cancers  such as prostate, eye, head, neck, breast and cervix is increasing. In this regard, different models of Pd- 103  seeds  have  been  designed  and  manufactured  at  the  Agricultural,  Medical  and  Industrial  Research  School (AMIRS) of Atomic Energy Organization of Iran. In this research, the dosimetric parameters of  the second model of Pd-103 seed manufactured at AMIRS have been calculated and measured.   Materials and Methods: The dosimetric parameters of the second Pd-103 seed manufactured at AMIRS  were determined according to TG-43U1 protocol usin...
Subjects
free text keywords: Brachytherapy, Pd-103 Seed, TG-43U1 Protocol, Monte Carlo Simulation, Thermoluminescent Dosimetry, Medical physics. Medical radiology. Nuclear medicine, R895-920
25 references, page 1 of 2

1. Bernard S, Vynckier S, Dosimetric study of a new polymer encapsulated palladium-103 seed, Phys Med Biol 2005; 50:1493-1504. [OpenAIRE]

2. Reniers B, Vynckier S, Scalliet P, Dosimetric study of a new palladium seed, Applid Radiation and Isotopes 2002; 57:805-11. [OpenAIRE]

6. Cutrer L M, Hollywood N, Calif, Laser welded brachytherapy source and method of making the source, Patent No: U. S. P 5,997,463, 1999; 1-14.

7. Nath R, Anderson L L, Meli J A, Olch A J, Stitt J A, Williamson J F, Code of practice for brachytherapy physics: Report of the AAPM Radiation Therapy Committee Task Group No. 56, Med Phys 1997; 24(10), 1557-98.

8. Khan F M , The Physics of Radiation Therapy, Ed. William & Wilkins, 1995.

9. Rivard M J, Coursey B M, DeWerd L A, Hanson W F, Huq M S, Ibbott G S, Mitch M G, Nath R, Williamson J F, Update of AAPM Task Group No.43 Report: A revised AAPM protocol for brachytherapy dose calculations, Med Phys 2004; 31(3):633-74.

11. Anagnostopoulas G, Baltas D, Karaiskos P, Sandilos P, Papagiannis P and Sakelliou L, Thermoluminescent dosimetry of the selectseed 125I interstitial brachythrapy seed, Med Phys 2002; 29(5). [OpenAIRE]

12. Patel N S, Chiu-Tsao S, Williamson J F, Fan P, Duckworth T, Shasha D and Harrison L B, Thermoluminescent dosimetry of the Symmetra 125I model I25.S06 interstitial brachythrapy seed, Med Phys 2001; 28(8): 1761-69.

13. Meigooni A S, Yoe-Sein M M, Al-Otoom A Y, Sowards K T, Determination of the dosimetric characteristics of the intersource 125I brachytherapy source, Appl Rad And Isotopes 2002; 56:589-99. [OpenAIRE]

14. Peterson S W and Thomadson B, Measurement of the dosimetric constants for a new 103Pd brachytherapy source, Med Phys 2002; 1: 110-9.

15. Ghonchenazi M G, Determination of dosimetry parameters of Pd-103 source using TLD dosimeters and Monte Carlo simulation method, M. Sc. thesis 1385; Isfahan University of Medical Science.

16. Meigooni A S, Recent developments in brachytherapy source dosimetry, Iran J Radiat Res 2004; 2(3): 97-105.

17. Briesmeister, Editor J F, MCNP-4C, A General Monte Carlo N Particle Transport Code System Version 4C, Los Alamos National Laboratory LA-13709-M, 2000.

18. Rivard M J, A discretized approach to determining TG-43 brachytherapy dosimetry parameters: case study using Monte Carlo calculation for the 103Pd MED3633 source, Applied Radiation and Isotopes 2001; 55: 775-82.

19. Raisali G, Mokhles Gerami F, Khodadadi R, Piroozfar B, Determination of dosimetry parameters for low energy brachytherapy sources based upon TG43-U1 protocol using different MCNP tallies, J Nuclear Science and Technology 2006; 35:29-36.

25 references, page 1 of 2
Powered by OpenAIRE Open Research Graph
Any information missing or wrong?Report an Issue
publication . Article . 2008

DETERMINATION OF DOSIMETRIC PARAMETERS OF THE SECOND MODEL OF PD-103 SEED MANUFACTURED AT AGRICULTURAL, MEDICAL AND INDUSTRIAL RESEARCH SCHOOL

Mahdi Sadeghi;